AU2012237028C1 - Aureobasidin derivatives and methods of synthesis - Google Patents

Aureobasidin derivatives and methods of synthesis Download PDF

Info

Publication number
AU2012237028C1
AU2012237028C1 AU2012237028A AU2012237028A AU2012237028C1 AU 2012237028 C1 AU2012237028 C1 AU 2012237028C1 AU 2012237028 A AU2012237028 A AU 2012237028A AU 2012237028 A AU2012237028 A AU 2012237028A AU 2012237028 C1 AU2012237028 C1 AU 2012237028C1
Authority
AU
Australia
Prior art keywords
compound
formula
alkyl
solvent
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012237028A
Other languages
English (en)
Other versions
AU2012237028B2 (en
AU2012237028A1 (en
Inventor
Ake P. Elhammer
Peter Wuts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AureoGen Biosciences Inc
Original Assignee
AureoGen Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AureoGen Biosciences Inc filed Critical AureoGen Biosciences Inc
Publication of AU2012237028A1 publication Critical patent/AU2012237028A1/en
Application granted granted Critical
Publication of AU2012237028B2 publication Critical patent/AU2012237028B2/en
Publication of AU2012237028C1 publication Critical patent/AU2012237028C1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2012237028A 2011-04-01 2012-03-23 Aureobasidin derivatives and methods of synthesis Ceased AU2012237028C1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161470750P 2011-04-01 2011-04-01
US61/470,750 2011-04-01
US201161535018P 2011-09-15 2011-09-15
US61/535,018 2011-09-15
PCT/US2012/030269 WO2012134989A1 (en) 2011-04-01 2012-03-23 Aureobasidium derivatives and methods of synthesis

Publications (3)

Publication Number Publication Date
AU2012237028A1 AU2012237028A1 (en) 2013-10-31
AU2012237028B2 AU2012237028B2 (en) 2017-04-06
AU2012237028C1 true AU2012237028C1 (en) 2017-12-07

Family

ID=45929626

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012237028A Ceased AU2012237028C1 (en) 2011-04-01 2012-03-23 Aureobasidin derivatives and methods of synthesis

Country Status (8)

Country Link
US (1) US8906848B2 (enExample)
EP (1) EP2694532B1 (enExample)
JP (2) JP6058625B2 (enExample)
AU (1) AU2012237028C1 (enExample)
CA (1) CA2832041C (enExample)
ES (1) ES2866698T3 (enExample)
PL (1) PL2694532T3 (enExample)
WO (1) WO2012134989A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
WO2018031521A1 (en) * 2016-08-08 2018-02-15 Aureogen Biosciences, Inc. Aureobasidium derivatives and methods of synthesis
WO2018102345A1 (en) * 2016-11-30 2018-06-07 Agrobiologics Llc Use of the antifungal aureobasidin a in agriculture
WO2020018888A1 (en) * 2018-07-20 2020-01-23 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510271A1 (en) * 1989-07-11 1992-10-28 Takara Shuzo Co. Ltd. Novel R106 compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
JP3480848B2 (ja) 1992-06-19 2003-12-22 タカラバイオ株式会社 環状ペプチドの合成方法
US5716981A (en) 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
EP0687686B1 (en) * 1993-12-27 2000-08-30 Takara Shuzo Co. Ltd. Aureobasidins
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510271A1 (en) * 1989-07-11 1992-10-28 Takara Shuzo Co. Ltd. Novel R106 compounds

Also Published As

Publication number Publication date
JP6313369B2 (ja) 2018-04-18
US8906848B2 (en) 2014-12-09
CA2832041A1 (en) 2012-10-04
AU2012237028B2 (en) 2017-04-06
EP2694532A1 (en) 2014-02-12
WO2012134989A1 (en) 2012-10-04
AU2012237028A1 (en) 2013-10-31
EP2694532B1 (en) 2021-04-21
JP2016196489A (ja) 2016-11-24
JP2014515741A (ja) 2014-07-03
CA2832041C (en) 2020-12-01
US20140024578A1 (en) 2014-01-23
PL2694532T3 (pl) 2021-08-23
JP6058625B2 (ja) 2017-01-11
ES2866698T3 (es) 2021-10-19

Similar Documents

Publication Publication Date Title
EP4309741A1 (en) Cyclic compound having inhibitory effect selective for kras but not for hras and nras
JP6313369B2 (ja) オーレオバシジン誘導体および合成方法
EP4512818A1 (en) Cyclic compound having selective kras inhibitory effect on hras and nras
CA2699289C (en) Thiazolidinedione analogues for the treatment of hypertension
NZ571871A (en) Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
EP3049089A1 (en) Highly potent glucocorticoids
JP2014515741A5 (enExample)
EP2560615A1 (en) Thiazolidinedione analogues
WO2011153423A2 (en) Processes and intermediates
WO2015013187A1 (en) Ppar-sparing compounds for the treatment of metabolic diseases
WO2011017244A1 (en) Polymorphs of 5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)-1,3-thiazolidine-2,4-dione (mitoglitazone)
WO2014201332A1 (en) Pharmaceutical combinations useful for treating rheumatoid arthritis
EP3525870B1 (en) Highly potent glucocorticoids
US11066447B2 (en) Aureobasidium derivatives and methods of synthesis
AU2013200104B2 (en) Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
WO2012158513A1 (en) Processes and intermediates

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 03 JUL 2017

TH Corrigenda

Free format text: IN VOL 31 , NO 36 , PAGE(S) 5310 UNDER THE HEADING AMENDMENTS - APPLICATION FOR AMENDMENTS UNDER THE NAME AUREOGEN BIOSCIENCES, INC., APPLICATION NO. 2012237028 CORRECT THE DATE OF THE STATEMENTS FILED TO READ 3 JUL AND 18 AUG 2017

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 03 JUL 2017 AND 18 AUG 2017

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired